{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:05:18Z","timestamp":1788267918265,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10549-022-06748-4","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T10:03:08Z","timestamp":1664186588000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer"],"prefix":"10.1007","volume":"196","author":[{"given":"Hikari","family":"Jimbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-0768","authenticated-orcid":false,"given":"Yoshiya","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Shikanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsue","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9226-895X","authenticated-orcid":false,"given":"Junichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"6748_CR1","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I et al (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383\u20135391","journal-title":"Cancer Res"},{"key":"6748_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jso.25290","volume":"119","author":"FCM Cananzi","year":"2019","unstructured":"Cananzi FCM, Minerva EM, Sam\u00e0 L, Ruspi L, Sicoli F, Conti L et al (2019) Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol 119:12\u201320","journal-title":"J Surg Oncol"},{"key":"6748_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/bjc.2015.183","volume":"113","author":"CH Koh","year":"2015","unstructured":"Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH et al (2015) Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113:150\u2013158","journal-title":"Br J Cancer"},{"key":"6748_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-016-2352-8","volume":"16","author":"Y Chen","year":"2016","unstructured":"Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C et al (2016) Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study. BMC Cancer 16:320","journal-title":"BMC Cancer"},{"key":"6748_CR5","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1038\/bjc.2014.163","volume":"110","author":"S Krenn-Pilko","year":"2014","unstructured":"Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A et al (2014) The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 110:2524\u20132530","journal-title":"Br J Cancer"},{"key":"6748_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1245\/s10434-015-4934-0","volume":"23","author":"Y Asano","year":"2016","unstructured":"Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T et al (2016) Predictive value of neutrophil\/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer. Ann Surg Oncol 23:1104\u20131110","journal-title":"Ann Surg Oncol"},{"key":"6748_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12282-020-01069-0","volume":"27","author":"M Myojin","year":"2020","unstructured":"Myojin M, Horimoto Y, Ito M, Kitano S, Ishizuka Y, Sasaki R et al (2020) Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer. Breast Cancer 27:732\u2013738","journal-title":"Breast Cancer"},{"key":"6748_CR8","doi-asserted-by":"crossref","first-page":"117822342110651","DOI":"10.1177\/11782234211065148","volume":"16","author":"A Shikanai","year":"2022","unstructured":"Shikanai A, Horimoto Y, Ishizuka Y, Uomori T, Nakai K, Arakawa A et al (2022) Clinicopathological features related to the efficacy of CDK4\/6 inhibitor-based treatments in metastatic breast cancer. Breast Cancer (Auckl) 16:11782234211065148","journal-title":"Breast Cancer (Auckl)"},{"key":"6748_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10549-020-05626-1","volume":"181","author":"J Watanabe","year":"2020","unstructured":"Watanabe J, Saito M, Horimoto Y, Nakamoto S (2020) A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience. Breast Cancer Res Treat 181:211\u2013220","journal-title":"Breast Cancer Res Treat"},{"key":"6748_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1186\/s12885-018-4888-2","volume":"18","author":"K Araki","year":"2018","unstructured":"Araki K, Ito Y, Fukada I, Kobayashi K, Miyagawa Y, Imamura M et al (2018) Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel. BMC Cancer 18:982\u2013982","journal-title":"BMC Cancer"},{"key":"6748_CR11","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.4049\/jimmunol.139.7.2406","volume":"139","author":"A El-Hag","year":"1987","unstructured":"El-Hag A, Clark RA (1987) Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 139:2406\u20132413","journal-title":"J Immunol"},{"key":"6748_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","volume":"105","author":"JS Palumbo","year":"2005","unstructured":"Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell\u2013mediated elimination of tumor cells. Blood 105:178\u2013185","journal-title":"Blood"},{"key":"6748_CR13","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"HG Kopp","year":"2009","unstructured":"Kopp HG, Placke T, Salih HR (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 69:7775\u20137783","journal-title":"Cancer Res"},{"key":"6748_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1189\/jlb.0907615","volume":"83","author":"N Li","year":"2008","unstructured":"Li N (2008) Platelet-lymphocyte cross-talk. J Leukoc Biol 83:1069\u20131078","journal-title":"J Leukoc Biol"},{"key":"6748_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","volume":"75","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang H, Wang Y, Brown ZJ, Xia Y, Huang Z et al (2021) Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. J Hepatol 75:1271\u20131283","journal-title":"J Hepatol"},{"key":"6748_CR16","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-03-0760","volume":"10","author":"JE De Larco","year":"2004","unstructured":"De Larco JE, Wuertz BRK, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10:4895\u20134900","journal-title":"Clin Cancer Res"},{"key":"6748_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","volume":"9","author":"NM Bambace","year":"2011","unstructured":"Bambace NM, Holmes CE (2011) The platelet contribution to cancer progression. J Thromb Haemost 9:237\u2013249","journal-title":"J Thromb Haemost"},{"key":"6748_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.167.2.691","volume":"167","author":"SE Murray","year":"2001","unstructured":"Murray SE, Lallman HR, Heard AD, Rittenberg MB, Stenzel-Poore MP (2001) A genetic model of stress displays decreased lymphocytes and impaired antibody responses without altered susceptibility to Streptococcus pneumoniae. J Immunol 167:691\u2013698","journal-title":"J Immunol"},{"key":"6748_CR19","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1084\/jem.20141132","volume":"211","author":"A Nakai","year":"2014","unstructured":"Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K (2014) Control of lymphocyte egress from lymph nodes through \u03b22-adrenergic receptors. J Exp Med 211:2583\u20132598","journal-title":"J Exp Med"},{"key":"6748_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s12282-020-01067-2","volume":"27","author":"Y Miyoshi","year":"2020","unstructured":"Miyoshi Y, Yoshimura Y, Saito K, Muramoto K, Sugawara M, Alexis K et al (2020) High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin\u2014but not with treatment of physician\u2019s choice\u2014in the EMBRACE study. Breast Cancer 27:706\u2013715","journal-title":"Breast Cancer"},{"key":"6748_CR21","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.2147\/CMAR.S187233","volume":"11","author":"J Hong","year":"2019","unstructured":"Hong J, Chen X, Gao W, Zhu S, Wu J, Huang O et al (2019) A high absolute lymphocyte count predicts a poor prognosis in HER-2-positive breast cancer patients treated with trastuzumab. Cancer Manag Res 11:3371\u20133379","journal-title":"Cancer Manag Res"},{"key":"6748_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41416-021-01391-0","volume":"125","author":"SM Ko","year":"2021","unstructured":"Ko SM, Lee J, Bae SJ, Baik SJ, Ji J, Kim D et al (2021) Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients. Br J Cancer 125:119\u2013125","journal-title":"Br J Cancer"},{"key":"6748_CR23","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-17-1323","volume":"24","author":"A Afghahi","year":"2018","unstructured":"Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB et al (2018) Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer. Clin Cancer Res 24:2851\u20132858","journal-title":"Clin Cancer Res"},{"key":"6748_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1075-122X.2004.21290.x","volume":"10","author":"JS Blake-Mortimer","year":"2004","unstructured":"Blake-Mortimer JS, Sephton SE, Carlson RW, Stites D, Spiegel D (2004) Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Breast J 10:195\u2013199","journal-title":"Breast J"},{"key":"6748_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/1346-8138.14865","volume":"46","author":"Y Muto","year":"2019","unstructured":"Muto Y, Kitano S, Tsutsumida A, Namikawa K, Takahashi A, Nakamura Y et al (2019) Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab. J Dermatol 46:498\u2013506","journal-title":"J Dermatol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06748-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T14:50:17Z","timestamp":1676904617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6748"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06748-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of Juntendo University Hospital (H19-0289) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An opt-out approach was used with the disclosure of website.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}